Product Code: GVR-3-68038-124-5
Cranial Implants Market Growth & Trends:
The global cranial implants market size is anticipated to reach USD 2.09 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.5% from 2025 to 2030. Increasing cases of Traumatic Brain Injury (TBI) and brain tumors are anticipated to boost the market.
The cranial implants market is experiencing a shift toward advanced materials that offer enhanced biocompatibility and functionality. While polymers and metals remain the primary materials, ceramic implants are gaining traction due to their favorable aesthetic outcomes and similarity to natural bone.
Technological advancements, including 3D printing, Computer-aided Design and Manufacturing (CAD/CAM) for implant creation, and tissue engineering therapies aimed at regenerating larger bone defects, are significant drivers of market expansion. For instance, in April 2024, 3D Systems received Food and Drug Administration (FDA) 510(k) clearance for its patient-specific VSP PEEK Cranial Implant, which is manufactured using 3D printing technology. This regulatory clearance highlights the growing adoption of 3D printing in standard clinical practice and its potential to significantly transform cranial reconstruction procedures.
Cranial Implants Market Report Highlights:
- By product, the customized segment held the largest revenue share approximately about 87% in 2024, attributed to the increasing number of patients suffering from brain defects due to brain tumors and TBIs
- By material, polymer segment held a major market share in 2024, owing to increasing usage of polymer in cranioplasty surgical procedure for treatment of skull defects and brain tumor
- Hospitals led the cranial implants market with a revenue share in 2024 due to the availability of skilled neurosurgeons and improving healthcare infrastructure in developing countries
- North America dominated the global market with a major share in 2024, owing to the adoption of technologically advanced products, government initiatives, and high disposable income
- Key players opt for technologically enhanced products to gain a competitive edge. In August 2024, Longeviti Neuro Solutions, a neurotechnology company headquartered in Maryland, was granted a U.S. patent for its innovative translucent prosthetic cranial implant designed for application in neurosurgical procedures.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Material
- 1.2.3. End use
- 1.2.4. Regional Scope
- 1.2.5. Estimates and Forecasts Timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.4.3. Secondary Sources
- 1.4.4. Primary Research
- 1.4.5. Details of Primary Research
- 1.5. Information or Data Analysis
- 1.5.1. Data Analysis Models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product Outlook
- 2.2.2. Material Outlook
- 2.2.3. End use Outlook
- 2.2.4. Regional Outlook
- 2.3. Competitive Insights
Chapter 3. Cranial Implants Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Cranial Implants Market Analysis tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrant
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political Landscape
- 3.3.2.2. Technological Landscape
- 3.3.2.3. Economic Landscape
Chapter 4. Cranial Implants Market: Product Estimates & Trend Analysis
- 4.1. Product Segment Dashboard
- 4.2. Cranial Implants Market: Product Movement Analysis
- 4.3. Global Cranial Implants Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Customized
- 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.5. Non-Customized
- 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. Cranial Implants Market: Material Estimates & Trend Analysis
- 5.1. Material Segment Dashboard
- 5.2. Cranial Implants Market: Material Movement Analysis
- 5.3. Global Cranial Implants Market Size & Trend Analysis, by Material, 2018 to 2030 (USD Million)
- 5.4. Polymer
- 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 5.5. Ceramic
- 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 5.6. Metal
- 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 6. Cranial Implants Market: End Use Estimates & Trend Analysis
- 6.1. End Use Segment Dashboard
- 6.2. Cranial Implants Market: End Use Movement Analysis
- 6.3. Global Cranial Implants Market Size & Trend Analysis, by End use, 2018 to 2030 (USD Million)
- 6.4. Hospital
- 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.5. Neurosurgery Centers
- 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 7. Cranial Implants Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Dashboard
- 7.2. Regional Market Share Analysis, 2024 & 2030
- 7.3. Continuous Bioprocessing Market By Region: Key Takeaways
- 7.4. North America
- 7.4.1. U.S.
- 7.4.1.1. Key Country Dynamics
- 7.4.1.2. Regulatory Framework/ Reimbursement Structure
- 7.4.1.3. Competitive Scenario
- 7.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.4.2. Canada
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Regulatory Framework/ Reimbursement Structure
- 7.4.2.3. Competitive Scenario
- 7.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.4.3. Mexico
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Regulatory Framework/ Reimbursement Structure
- 7.4.3.3. Competitive Scenario
- 7.4.3.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5. Europe
- 7.5.1. UK
- 7.5.1.1. Key Country Dynamics
- 7.5.1.2. Regulatory Framework/ Reimbursement Structure
- 7.5.1.3. Competitive Scenario
- 7.5.1.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5.2. Germany
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Regulatory Framework/ Reimbursement Structure
- 7.5.2.3. Competitive Scenario
- 7.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5.3. France
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Regulatory Framework/ Reimbursement Structure
- 7.5.3.3. Competitive Scenario
- 7.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5.4. Italy
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Regulatory Framework/ Reimbursement Structure
- 7.5.4.3. Competitive Scenario
- 7.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5.5. Spain
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Regulatory Framework/ Reimbursement Structure
- 7.5.5.3. Competitive Scenario
- 7.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5.6. Denmark
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Regulatory Framework/ Reimbursement Structure
- 7.5.6.3. Competitive Scenario
- 7.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5.7. Sweden
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Regulatory Framework/ Reimbursement Structure
- 7.5.7.3. Competitive Scenario
- 7.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5.8. Norway
- 7.5.8.1. Key Country Dynamics
- 7.5.8.2. Regulatory Framework/ Reimbursement Structure
- 7.5.8.3. Competitive Scenario
- 7.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6. Asia Pacific
- 7.6.1. Japan
- 7.6.1.1. Key Country Dynamics
- 7.6.1.2. Regulatory Framework/ Reimbursement Structure
- 7.6.1.3. Competitive Scenario
- 7.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.2. China
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Regulatory Framework/ Reimbursement Structure
- 7.6.2.3. Competitive Scenario
- 7.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.3. India
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Regulatory Framework/ Reimbursement Structure
- 7.6.3.3. Competitive Scenario
- 7.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.4. Australia
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Regulatory Framework/ Reimbursement Structure
- 7.6.4.3. Competitive Scenario
- 7.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.5. South Korea
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Regulatory Framework/ Reimbursement Structure
- 7.6.5.3. Competitive Scenario
- 7.6.5.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.6. Thailand
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Regulatory Framework/ Reimbursement Structure
- 7.6.6.3. Competitive Scenario
- 7.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.7. Latin America
- 7.7.1. Brazil
- 7.7.1.1. Key Country Dynamics
- 7.7.1.2. Regulatory Framework/ Reimbursement Structure
- 7.7.1.3. Competitive Scenario
- 7.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.7.2. Argentina
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Regulatory Framework/ Reimbursement Structure
- 7.7.2.3. Competitive Scenario
- 7.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.8. MEA
- 7.8.1. South Africa
- 7.8.1.1. Key Country Dynamics
- 7.8.1.2. Regulatory Framework/ Reimbursement Structure
- 7.8.1.3. Competitive Scenario
- 7.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.8.2. Saudi Arabia
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Regulatory Framework/ Reimbursement Structure
- 7.8.2.3. Competitive Scenario
- 7.8.2.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.8.3. UAE
- 7.8.3.1. Key Country Dynamics
- 7.8.3.2. Regulatory Framework/ Reimbursement Structure
- 7.8.3.3. Competitive Scenario
- 7.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.8.4. Kuwait
- 7.8.4.1. Key Country Dynamics
- 7.8.4.2. Regulatory Framework/ Reimbursement Structure
- 7.8.4.3. Competitive Scenario
- 7.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. Key Company Heat Map Analysis, 2024
- 8.4. Company Profiles
- 8.4.1. B. Braun SE
- 8.4.1.1. Company Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. Johnson & Johnson Services, Inc.
- 8.4.2.1. Company Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. Stryker
- 8.4.3.1. Company Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. Zimmer Biomet
- 8.4.4.1. Company Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. Acumed LLC
- 8.4.5.1. Company Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. evonos GmbH & Co. KG
- 8.4.6.1. Company Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. Medartis AG
- 8.4.7.1. Company Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. Renishaw plc.
- 8.4.8.1. Company Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. Kelyniam Global Inc.
- 8.4.9.1. Company Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. Anatomics Pty Ltd
- 8.4.10.1. Company Overview
- 8.4.10.2. Financial Performance
- 8.4.10.3. Product Benchmarking
- 8.4.10.4. Strategic Initiatives